Cargando…
Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Autores principales: | Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K., Keyomarsi, Khandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480452/ https://www.ncbi.nlm.nih.gov/pubmed/26108797 http://dx.doi.org/10.1186/s13058-015-0572-5 |
Ejemplares similares
-
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2014) -
The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014) -
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
por: Hunt, Kelly K, et al.
Publicado: (2013) -
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration
por: Chen, Xian, et al.
Publicado: (2021) -
PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015)